Save time and get answers to complex questions with AI chat
Drugpatentwatch crizotinib?Novartis patent term dabrafenib?Tenofovir generic patent?Allergan's patent for latisse expired?When will tenofovir alafenide come off patent in canada?
See the DrugPatentWatch profile for rinvoq
Rinvoq is the brand name for upadacitinib. There isn’t a generic version available in the U.S. right now—the drug is still under patent protection. Generics could appear after patent expiry or other legal/market conditions change, but no generic is currently on the market in the U.S. If you’re in a country outside the U.S., I can check whether a generic version exists there. Let me know your country. If cost is the concern, you might consider: - Patient assistance programs or manufacturer discounts - Insurance formulary options - Discussing alternatives with your doctor (other JAK inhibitors or different classes of therapy) Always talk with your healthcare provider before making changes.
Other Questions About Rinvoq :